Seroatlas · Human Serome Atlas

FBLN5

Fibulin-5

Also known as: ARMD3, DANCE, EVEC, FBLN5_HUMAN, UP50

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UBX5
Gene
FBLN5
Ensembl
ENSG00000140092
Chromosome
14
Canonical length
448 aa
Protein class
Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Plasma membrane
Secretome location
Secreted to extracellular matrix
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

448 residues, UniProt reviewed canonical sequence.

>Q9UBX5|FBLN5
     1  MPGIKRILTV TILALCLPSP GNAQAQCTNG FDLDRQSGQC LDIDECRTIP EACRGDMMCV
    61  NQNGGYLCIP RTNPVYRGPY SNPYSTPYSG PYPAAAPPLS APNYPTISRP LICRFGYQMD
   121  ESNQCVDVDE CATDSHQCNP TQICINTEGG YTCSCTDGYW LLEGQCLDID ECRYGYCQQL
   181  CANVPGSYSC TCNPGFTLNE DGRSCQDVNE CATENPCVQT CVNTYGSFIC RCDPGYELEE
   241  DGVHCSDMDE CSFSEFLCQH ECVNQPGTYF CSCPPGYILL DDNRSCQDIN ECEHRNHTCN
   301  LQQTCYNLQG GFKCIDPIRC EEPYLRISDN RCMCPAENPG CRDQPFTILY RDMDVVSGRS
   361  VPADIFQMQA TTRYPGAYYI FQIKSGNEGR EFYMRQTGPI SATLVMTRPI KGPREIQLDL
   421  EMITVNTVIN FRGSSVIRLR IYVSQYPF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FBLN5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
668 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 668 nTPM
  • heart muscle: 181 nTPM
  • adipose tissue: 151 nTPM
  • endometrium: 135 nTPM
  • lung: 133 nTPM
  • gallbladder: 119 nTPM

Single-cell type

  • peritubular myoid cells: 856 nCPM
  • leydig cells: 706 nCPM
  • hepatic stellate cells: 465 nCPM
  • fibroblasts: 322 nCPM
  • fibro-adipogenic progenitors: 270 nCPM
  • decidual stromal cells: 254 nCPM

Immune cell

  • basophil: 6.7 nTPM
  • neutrophil: 2.7 nTPM
  • eosinophil: 2.4 nTPM
  • naive CD8 T-cell: 1.5 nTPM
  • gdT-cell: 0.8 nTPM
  • naive CD4 T-cell: 0.7 nTPM

Brain region

  • medulla oblongata: 27 nTPM
  • choroid plexus: 27 nTPM
  • spinal cord: 21 nTPM
  • cerebral cortex: 20 nTPM
  • basal ganglia: 18 nTPM
  • thalamus: 17 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FBLN5.

Disease | AllUniProt

Conditions FBLN5 is implicated in, by any mechanism.

Disease | GeneticClinVar

8 pathogenic / likely-pathogenic of 688 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.17
gnomAD pLI
1
gnomAD missense Z
1.56
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FBLN5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FBLN5 as an antibody target. Whether an autoantibody or antibody against FBLN5 could matter depends on whether native FBLN5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FBLN5 is annotated as secreted, so native FBLN5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label FBLN5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FBLN5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...